Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Paper
  • Published:

Sociodemographic factors associated with postprostatectomy radiotherapy

Prostate Cancer and Prostatic Diseases volume 8, pages 184–188 (2005)Cite this article

Abstract

Purpose:

To determine if nonclinical factors affect the use of adjuvant radiation therapy after surgical resection of the prostate gland.

Methods:

Using the National Cancer Institute's Surveillance Epidemiology and End Results (SEER) public use data files, we identified men with localized/regional prostate cancer who underwent postprostatectomy radiotherapy within 4 months of surgery. We used 2000 Census information to ascribe a median education and income level to these men based on the county of residence and ethnicity.

Results:

Of 34 763 men who underwent surgical resection, 1549 received postprostatectomy radiotherapy. Those with higher tumor grade and from certain geographic regions (Seattle and Hawaii) had significantly higher rates of radiotherapy while being older and from other geographic regions (Detroit, Utah, and New Mexico) was protective. The use of additional radiation therapy was not affected by ethnicity, income level, or educational attainment.

Conclusions:

We found no socioeconomic or demographic disparities in the receipt of postprostatectomy radiotherapy. Geographic variation in postprostatectomy radiotherapy may be explained by limited evidence supporting its use in clinical practice.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  1. Zincke H et al. Long-term (15 years) results after radical prostatectomy for clinically localized (stage T2c or lower) prostate cancer. J Urol 1994; 152: 1850.

    Article  CAS  PubMed  Google Scholar 

  2. Ragde H, Grado GL, Nadir BS . Brachytherapy for clinically localized prostate cancer: thirteen-year disease-free survival of 769 consecutive prostate cancer patients treated with permanent implants alone. Arch Esp Urol 2001; 54: 739.

    CAS  PubMed  Google Scholar 

  3. Pound CR et al. Natural history of progression after PSA elevation following radical prostatectomy. JAMA 1999; 281: 1591.

    Article  CAS  PubMed  Google Scholar 

  4. D'Amico AV et al. Biochemical outcome after radical prostatectomy or external beam radiation therapy for patients with clinically localized prostate carcinoma in the prostate specific antigen era. Cancer 2002; 95: 281.

    Article  PubMed  Google Scholar 

  5. Andriole GL . Adjuvant therapy for prostate cancer patients at high risk of recurrence following radical prostatectomy. Eur Urol 1997; 32 (Suppl 3): 65.

    PubMed  Google Scholar 

  6. Kamat AM et al. Identification of factors predicting response to adjuvant radiation therapy in patients with positive margins after radical prostatectomy. J Urol 2003; 170: 1860.

    Article  PubMed  Google Scholar 

  7. Valicenti RK, Gomella LG, Perez CA . Radiation therapy after radical prostatectomy: a review of the issues options. Semin Radiat Oncol 2003; 13: 130.

    Article  PubMed  Google Scholar 

  8. Partin AW et al. Contemporary update of prostate cancer staging nomograms (Partin Tables) for the new millennium. Urology 2001; 58: 843.

    Article  CAS  PubMed  Google Scholar 

  9. Powell IJ et al. Disease-free survival difference between African Americans, whites after radical prostatectomy for local prostate cancer: a multivariable analysis. Urology 2002; 59: 907.

    Article  PubMed  Google Scholar 

  10. Powell IJ et al. Prostate cancer biochemical recurrence stage for stage is more frequent among African-American than white men with locally advanced but not organ-confined disease. Urology 2000; 55: 246.

    Article  CAS  PubMed  Google Scholar 

  11. Underwood III W et al. Postprostatectomy cancer-free survival of African Americans is similar to non-African Americans after adjustment for baseline cancer severity. Urol Oncol 2004; 22: 20.

    Article  PubMed  Google Scholar 

  12. Hart KB et al. The impact of race on biochemical disease-free survival in early-stage prostate cancer patients treated with surgery or radiation therapy. Int J Radiat Oncol Biol Phys 1999; 45: 1235.

    Article  CAS  PubMed  Google Scholar 

  13. Tarman GJ et al. Impact of socioeconomic status race on clinical parameters of patients undergoing radical prostatectomy in an equal access health care system. Urology 2000; 56: 1016.

    Article  CAS  PubMed  Google Scholar 

  14. ACS: Cancer Facts Figures: American Cancer Society 2003.

  15. Surveillance E, End Results (SEER) Program (www.seer.cancer.gov.) Public-Use Data (1973–2001): National Cancer Institute, released 2003, based on November 2002 submission.

  16. Ayanian JZ et al. Use of adjuvant chemotherapy radiation therapy for colorectal cancer in a population-based cohort. J Clin Oncol 2003; 21: 1293.

    Article  PubMed  Google Scholar 

  17. Schrag D et al. Adjuvant chemotherapy use for Medicare beneficiaries with stage II colon cancer. J Clin Oncol 2002; 20: 3999.

    Article  CAS  PubMed  Google Scholar 

  18. Schrag D et al. Age adjuvant chemotherapy use after surgery for stage III colon cancer. J Natl Cancer Inst 2001; 93: 850.

    Article  CAS  PubMed  Google Scholar 

  19. Shavers VL et al. Race/ethnicity the receipt of watchful waiting for the initial management of prostate cancer. J Gen Intern Med 2004; 19: 146.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Klabunde CN et al. Trends black/white differences in treatment for nonmetastatic prostate cancer. Med Care 1998; 36: 1337.

    Article  CAS  PubMed  Google Scholar 

  21. Harlan L et al. Geographic age, racial variation in the treatment of local/regional carcinoma of the prostate. J Clin Oncol 1995; 13: 93.

    Article  CAS  PubMed  Google Scholar 

  22. Albain KS et al. Influence of patient characteristics socioeconomic factors geography, systemic risk on the use of breast-sparing treatment in women enrolled in adjuvant breast cancer studies: an analysis of two intergroup trials. J Clin Oncol 1996; 14: 3009.

    Article  CAS  PubMed  Google Scholar 

  23. Gilligan MA et al. Persistent differences in sociodemographic determinants of breast conserving treatment despite overall increased adoption. Med Care 2002; 40: 181.

    Article  PubMed  Google Scholar 

  24. Greenwald HP et al. Social factors treatment, survival in early-stage non-small cell lung cancer. Am J Public Health 1998; 88: 1681.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. VanEenwyk J, Campo JS, Ossiander EM . Socioeconomic demographic disparities in treatment for carcinomas of the colon rectum. Cancer 2002; 95: 39.

    Article  PubMed  Google Scholar 

  26. Cooper GS et al. Geographic patient variation among Medicare beneficiaries in the use of follow-up testing after surgery for nonmetastatic colorectal carcinoma. Cancer 1999; 85: 2124.

    Article  CAS  PubMed  Google Scholar 

  27. Hillner BE et al. Variation in staging treatment of local regional breast cancer in the elderly. Breast Cancer Res Treat 1996; 40: 75.

    Article  CAS  PubMed  Google Scholar 

  28. Richardson LC et al. Early-stage breast cancer treatment among medically underserved women diagnosed in a national screening program 1992–1995. Breast Cancer Res Treat 2001; 69: 133.

    Article  CAS  PubMed  Google Scholar 

  29. Bolla M et al. (EORTC 22911): Does post-operative radiotherapy after radical prostatectomy improve progression-free survival in PT3NO prostate cancer? ASCO, (abstract). 2004.

  30. Aranha O, Vaishampayan U . PSA relapse prostate cancer: the importance of tailored therapy. Urol Oncol 2004; 22: 62.

    Article  PubMed  Google Scholar 

  31. Nudell DM et al. Radiotherapy after radical prostatectomy: treatment outcomes and failure patterns. Urology 1999; 54: 1049.

    Article  CAS  PubMed  Google Scholar 

  32. Gomella LG, Zeltser I, Valicenti RK . Use of neoadjuvant and adjuvant therapy to prevent or delay recurrence of prostate cancer in patients undergoing surgical treatment for prostate cancer. Urology 2003; 62 (Suppl 1): 46.

    Article  PubMed  Google Scholar 

  33. Mosbacher MR et al. Postprostatectomy salvage radiation therapy for prostate cancer: impact of pathological and biochemical variables and prostate fossa biopsy. Cancer J 2002; 8: 242.

    Article  PubMed  Google Scholar 

  34. Johnson CW et al. Prognostic indicators for long term outcome following radical retropubic prostatectomy for prostate cancer involving the seminal vesicles. Urol Oncol 2004; 22: 107.

    Article  PubMed  Google Scholar 

  35. Hull GW et al. Cancer control with radical prostatectomy alone in 1,000 consecutive patients. J Urol 2002; 167: 528.

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

This work was supported in part by a grant from the A.F.U.D./AUA Research Scholar Program.

Author information

Authors and Affiliations

  1. Department of Urology, David Geffen School of Medicine, School of Public Health, Jonsson Comprehensive Cancer Center, University of California, Los Angeles, California, USA

    T L Krupski, L Kwan & M S Litwin

  2. Department of Health Services, David Geffen School of Medicine, School of Public Health, Jonsson Comprehensive Cancer Center, University of California, Los Angeles, California, USA

    T L Krupski, L Kwan & M S Litwin

Authors
  1. T L Krupski
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. L Kwan
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M S Litwin
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to T L Krupski.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Krupski, T., Kwan, L. & Litwin, M. Sociodemographic factors associated with postprostatectomy radiotherapy. Prostate Cancer Prostatic Dis 8, 184–188 (2005). https://doi.org/10.1038/sj.pcan.4500791

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.pcan.4500791

Keywords

This article is cited by

Search

Advanced search

Quick links